[Benzodiazepine use and misuse in France]

Presse Med. 2018 Oct;47(10):878-881. doi: 10.1016/j.lpm.2018.10.005. Epub 2018 Oct 25.
[Article in French]

Abstract

Benzodiazepine use remains high in France in 2015, especially among the elders. However, encouraging trend is observed regarding hypnotic benzodiazepines initiation: between 2008 and 2015, incident use of hypnotics, including that of Z-drugs, decreased while incident use of anxiolytics remained stable. Most of new benzodiazepine users (86 %) had treatment duration that complies with guidelines. Owing to the high number of user initiating a treatment each year and associated risks, the remaining 14 % of long-term users is of concern. Roughly half of benzodiazepine users presented with comorbidities and concurrent medications increasing the risk of adverse drug reactions, especially central nervous system depressant effects.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Anxiety Disorders / drug therapy*
  • Benzodiazepines / adverse effects*
  • Benzodiazepines / therapeutic use*
  • Cross-Sectional Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • France
  • Humans
  • Long-Term Care
  • Middle Aged
  • Prescription Drugs / adverse effects*
  • Prescription Drugs / therapeutic use*
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Substance-Related Disorders / epidemiology*

Substances

  • Prescription Drugs
  • Benzodiazepines